Over the past 30 years, DIPG Patients have participated in more than 250 Clinical Trials. None of these trials have shown any benefit in either the likelihood of survival or the median length of survival. In fact, they have been more detrimental to the Patients and their families due to the side effects from which the children suffer.
It is time for a whole new approach to this disease. TBL-12 and the Program the Cancer Wellness Clinic has instilled is that new approach. It is all-natural, non-toxic, non-invasive and has zero adverse side effects. It can be administered in a Clinical Environment as well as a Home Environment.
The Clinical Trial protocol is being developed in conjunction with, and monitored by, several Universities whose research staff oversee the work.